Our website got a glow-up!
Launching in the next few days — same mission, fresh new look.

Got feedback or ideas? Drop us a message here or email [email protected]

Sending deep gratitude & support from Down Under.

"WHAT IS IT REALLY LIKE TO LIVE WITH ALK ON TKI'S IN AUSTRALIA?"
Share your story in this important study. This is open to any Australian ALKie at Stage IIIB or IV on a TKI for more than 12 months. It will be an online interview for 30-60 minutes.
Email [email protected] to share your story.

- 36 Australians are diagnosed with lung cancer every day.
- Lung cancer is the leading cause of cancer death in Australia, but attracts less than 6% of cancer research funding.

Today we acknowledge those raising awareness & working towards better outcomes for lung cancer patients.

Our Chair Jon & Dep Chair Lisa with Prof Nick Pavlakis, Prof Ben Solomon & Prof Tom John at the @togaanz.bsky.social ASM - working together for better outcomes for ALK Positive patients.

We could not be prouder of our Dep Chair & friend Lisa Briggs - the recently announced recipient of the 2025 Jeannie Ferris Award. Bravo Lisa - thank you for all that you do. You are a force!

The TOGA/ALK Positive Australia Inspirational Grant applications are now open! youtu.be/DzZBR6DPAN8?...

🤝 Eligibility: Projects must involve consumer representatives.

Get ready to apply and make an impact!

Let’s work together to drive real change.

Find out more > buff.ly/2Tv3YUR

The ALK+ Australia & TOGA Inspirational Research Grant applications are now open! We are proudly seeking innovative research that makes a real difference for people living with ALK-positive lung cancer. thoraciconcology.org.au/inspirationa...

This recent presentation on the ALK+ vaccine & current research being undertaken in the US is truly a MUST WATCH. It brings true hope. Thank you to everyone involved, we are cheering you on from Down Under!
youtu.be/GxrUsGIAFUs?...

ALK+ Community - many businesses make notable donations to charities at this time of year, for tax benefits & to demonstrate corporate social responsibility. If you know a decision maker in a the corporate world please put forward our charity for their consideration. More Research = More Life.

A wonderful, inspiring initiative that provides the entire ALK+ world with hope. Thank you!

CALLING RESEARCHERS! The ALK Positive Australia & TOGA Inspirational Research Grant for ALK+ NSCLC is back. We are seeking innovative research that makes a real difference for people living with ALK-positive lung cancer.

Now is the time to prepare a proposal. Further information coming soon.

One of our favourite days of the year. Go Research!

Promising signals from the ALEK-B ph 2 trial: combining alectinib w bevacizumab achieved 97.1% 12-mo PFS & median PFS of 39.6 months in ALK+ #NSCLC. Intracranial control also notably strong.

Could this combo help overcome resistance in more aggressive ALK variants?
#research #lungcancer

🎙️ Vaccines in Thoracic Oncology: The Next Frontier in Immunotherapy

Join Prof Tom John, Prof Ken O'Byrne and special guest Prof Georgina Long AO as they delve into technological advances spurred by COVID-19 vaccine development, promising results from recent melanoma and lung cancer vaccine trials

Our Chairperson Jon advocating for molecular testing for all lung cancer patients on the national news, and raising awareness for ALK Positive lung cancer. youtu.be/eoAT1mDrKnM

We’re proud to have Dr. Ken Culver representing @ALK_Positive at #AACR25 in Chicago this week!

We’re also partnering with @AACR on a $130K, 2-year fellowship supporting ALK+ lung cancer research 🌍 — open globally!

Apply by May 15: www.aacr.org/grants/aacr-...

What if a leukemia drug could help treat ALK+ lung cancer?

A new trial at @UMRogelCancerCtr is exploring gilteritinib—FDA-approved for leukemia—as a way to overcome resistance in ALK+ NSCLC.

🔗 Read the story: www.alkpositive.org/blog/2024/5/...
#DrugRepurposing #ALKPositive

Congratulations to all involved in this incredible initiative for LC patients.

A must watch for anyone interested in ALK+ Lung Cancer & the advances being made in personalising treatment plans & understanding the behaviour of this cancer. A/Prof Chin talks about her incredible research project (funded by the TOGA/ALK+ Australia Inspirational grant).
youtu.be/w9M-4M9fNT8